4:持股變動聲明-高管 PARSLOW JAMES F
XENETIC BIOSCIENCES INC C/WTS 11/07/2024 (TO PUR COM) | SC 13D/A:超過5%持股股東披露文件(修正)-Dmitry Genkin(14.0%),CLS Therapeutics Ltd.(9.6%)等
XENETIC BIOSCIENCES INC C/WTS 11/07/2024 (TO PUR COM) | 4:持股變動聲明-董事 Mizrahy Moshe
XENETIC BIOSCIENCES INC C/WTS 11/07/2024 (TO PUR COM) | 3:首次持股聲明-董事 Mizrahy Moshe
XENETIC BIOSCIENCES INC C/WTS 11/07/2024 (TO PUR COM) | 4:持股變動聲明-高管 Lockshin Curtis
XENETIC BIOSCIENCES INC C/WTS 11/07/2024 (TO PUR COM) | 4:持股變動聲明-首席財務官 PARSLOW JAMES F
XENETIC BIOSCIENCES INC C/WTS 11/07/2024 (TO PUR COM) | 4:持股變動聲明-董事 Kornberg Roger D.
XENETIC BIOSCIENCES INC C/WTS 11/07/2024 (TO PUR COM) | 4:持股變動聲明-董事 Borisenko Grigory G.
XENETIC BIOSCIENCES INC C/WTS 11/07/2024 (TO PUR COM) | 4:持股變動聲明-董事 Dastoor Firdaus J.
XENETIC BIOSCIENCES INC C/WTS 11/07/2024 (TO PUR COM) | 4:持股變動聲明-董事 Callaway James Eric
XENETIC BIOSCIENCES INC C/WTS 11/07/2024 (TO PUR COM) | 4:持股變動聲明-董事 VINOGRADOV ALEXEY ANDREEVICH
XENETIC BIOSCIENCES INC C/WTS 11/07/2024 (TO PUR COM) | 4:持股變動聲明-董事 Logal Adam
XENETIC BIOSCIENCES INC C/WTS 11/07/2024 (TO PUR COM) | SC 13D/A:超過5%持股股東披露文件(修正)-Dmitry Genkin(13.0%),CLS Therapeutics Ltd.(9.6%)等
XENETIC BIOSCIENCES INC C/WTS 11/07/2024 (TO PUR COM) | SC 13D:超過5%持股股東披露文件-CLS Therapeutics Ltd.(9.7%),Dmitry Genkin(9.7%)等
XENETIC BIOSCIENCES INC C/WTS 11/07/2024 (TO PUR COM) | 4:持股變動聲明
XENETIC BIOSCIENCES INC C/WTS 11/07/2024 (TO PUR COM) | 4:持股變動聲明
XENETIC BIOSCIENCES INC C/WTS 11/07/2024 (TO PUR COM) | 4:持股變動聲明
XENETIC BIOSCIENCES INC C/WTS 11/07/2024 (TO PUR COM) | 4:持股變動聲明
XENETIC BIOSCIENCES INC C/WTS 11/07/2024 (TO PUR COM) | 4:持股變動聲明
XENETIC BIOSCIENCES INC C/WTS 11/07/2024 (TO PUR COM) | 4:持股變動聲明